BANK OF MONTREAL /CAN/ - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 46 filers reported holding FATE THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$933,000
-59.4%
11,805
-42.5%
0.00%
-100.0%
Q4 2020$2,297,000
+1564.5%
20,514
+517.3%
0.00%
Q3 2020$138,000
-23.8%
3,323
-33.4%
0.00%
Q2 2020$181,000
+20.7%
4,988
-34.8%
0.00%
Q4 2019$150,000
+111.3%
7,656
+66.8%
0.00%
Q3 2019$71,000
-20.2%
4,589
+4.8%
0.00%
Q2 2019$89,0004,378
+43680.0%
0.00%
Q1 2019$0
-100.0%
10
-99.4%
0.00%
Q4 2018$20,000
+17.6%
1,554
+48.9%
0.00%
Q3 2018$17,000
+41.7%
1,044
+1.5%
0.00%
Q2 2018$12,000
+71.4%
1,029
+51.3%
0.00%
Q1 2018$7,000
-61.1%
680
-77.3%
0.00%
Q4 2017$18,0003,000
+17547.1%
0.00%
Q3 2017$017
+30.8%
0.00%
Q4 2016$013
-7.1%
0.00%
Q3 2016$014
-95.1%
0.00%
Q2 2016$0285
+3971.4%
0.00%
Q1 2016$07
-41.7%
0.00%
Q4 2015$012
-61.3%
0.00%
Q3 2015$031
+34.8%
0.00%
Q2 2015$0
-100.0%
23
-98.8%
0.00%
Q1 2015$10,0002,0000.00%
Other shareholders
FATE THERAPEUTICS INC shareholders Q1 2016
NameSharesValueWeighting ↓
Polaris Venture Management Co. V, L.L.C. 569,889$46,987,00060.92%
Johnson & Johnson Innovation - JJDC, Inc. 3,379,064$278,604,00036.08%
Darwin Global Management, Ltd. 1,370,133$112,967,00022.12%
Redmile Group, LLC 12,957,222$1,068,323,00015.05%
Copernicus Capital Management, LLC 8,000$660,00010.66%
Casdin Capital, LLC 3,400,000$280,330,0008.35%
Grosvenor Holdings, L.L.C. 1,123,576$92,639,0006.81%
DAFNA Capital Management LLC 314,360$25,919,0006.15%
Ally Bridge Group (NY) LLC 270,000$22,262,0004.27%
Ghost Tree Capital, LLC 185,000$15,253,0003.58%
View complete list of FATE THERAPEUTICS INC shareholders